Digital inhaled device specialist Adherium Limited (ASX:ADR) has reached an agreement of terms with leading respiratory company Monaghan Medical Corporation to support the introduction of its Hailie platform and technology into specialist respiratory centres in the United States.
CEO Mike Motion said this agreement progresses Adherium’s refocussed commercialisation plan targeting the estimated 1.5 million severe uncontrolled Asthma and COPD (Chronic Obstructive Pulmonary Disease) patients where adherence is critical. Within this patient group healthcare burden and cost is highest, and the impact of Adherium’s technology on clinical outcomes and costs is best demonstrated.
With feasibility testing and internal training completed the next step with Monaghan is to pilot the operational and commercial programme. This phase will complete towards the end of Q1 calendar 2021.
Mr Motion said the adoption of reimbursement for remote patient monitoring in the US has accelerated during COVID-19.
He said Adherium and Monaghan believe there is an opportunity to strengthen differentiation with an innovative digital respiratory value proposition combining the Hailie platform with Monaghan’s market leading Aero-Chamber in Asthma and Aerobika in COPD.
The introduction of the Hailie platform and technology will begin with eight specialist respiratory centres across six states in November as the precursor to wider commercialisation planned from Q2 calendar 2021.
This is an important step for Adherium with our Hailie platform and sensors placed with customers and fully supported by Monaghan’s professional sales and clinical team,” Mr Motion said.
“We have worked closely with Monaghan and adapted our training programs, systems, and support materials to meet patient needs and ensure alignment to Monaghan’s operational model.
“Our technology will secure recurring revenue from sensor sales and data access which will enable Adherium with Monaghan to commercially address patients who are difficult to treat Asthmatics and late stage COPD patients of which there are more than 8 million in the US alone.”
